NEW YORK (Reuters Health) – Patients with an acute coronary syndrome referred for invasive treatment have similar outcomes whether they are given double-dose or standard-dose clopidogrel plus higher-dose…
NEW YORK (Reuters Health) – By lowering heart rate, the selective sinoatrial current inhibitor ivabradine improves outcomes in patients with chronic heart failure and an elevated heart rate,…
NEW YORK (Reuters Health) – Men undergoing androgen deprivation therapy for prostate cancer halve their risk of vertebral fractures if they take the selective estrogen receptor modulator toremifene…
NEW YORK (Reuters Health) – While clopidogrel’s effectiveness in the treatment of acute coronary syndromes is affected by a patient’s genotype, the efficacy of ticagrelor is not. Therefore,…
NEW YORK (Reuters Health) – The transdermal estradiol gel 0.1% (Divigel) is effective for relieving moderate to severe vasomotor symptoms associated with menopause regardless of the woman’s age…
NEW YORK (Reuters Health) – A Canadian study has identified several readily available clinical factors that help determine the risk of fractures in men with prostate cancer undergoing…
NEW YORK (Reuters Health) – The incidence of inguinal hernia after radical retropubic prostatectomy can be reduced by a simple surgical procedure performed during the operation, a Swedish…
NEW YORK (Reuters Health) – Women with heavy menstrual bleeding may find that the levonorgestrel-releasing intrauterine system (Mirena; Bayer Schering) is more effective than oral medroxyprogesterone acetate in…
NEW YORK (Reuters Health) – The intensity of bortezomib-based regimens used to treat multiple myeloma in elderly patents can be reduced in order to lessen toxicity, without jeopardizing…
